Heart Test Laboratories (NASDAQ:HSCS) Shares Down 1.5% – Time to Sell?

Heart Test Laboratories, Inc. (NASDAQ:HSCS)’s share price traded down 1.5% during mid-day trading on Friday . The stock traded as low as $2.57 and last traded at $2.59. 17,903 shares changed hands during trading, a decline of 87% from the average session volume of 140,511 shares. The stock had previously closed at $2.63.

Wall Street Analyst Weigh In

Separately, Ascendiant Capital Markets reiterated a “buy” rating and set a $15.00 price target on shares of Heart Test Laboratories in a report on Monday, September 23rd.

Heart Test Laboratories Trading Down 1.5 %

The business has a 50 day simple moving average of $3.40 and a two-hundred day simple moving average of $4.47. The company has a current ratio of 4.49, a quick ratio of 4.02 and a debt-to-equity ratio of 0.08. The company has a market cap of $2.36 million, a PE ratio of -0.12 and a beta of 3.27.

Heart Test Laboratories (NASDAQ:HSCS) last released its earnings results on Thursday, September 12th. The company reported ($2.64) earnings per share for the quarter. On average, analysts forecast that Heart Test Laboratories, Inc. will post -9.82 EPS for the current fiscal year.

About Heart Test Laboratories

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.